tiprankstipranks
Trending News
More News >
PEPTONIC medical AB (DE:28L)
FRANKFURT:28L
Germany Market
Advertisement

PEPTONIC medical AB (28L) Income Statement

Compare
0 Followers

PEPTONIC medical AB Income Statement

Last quarter (Q2 2022), PEPTONIC medical AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, PEPTONIC medical AB's net income was $-9.04M. See PEPTONIC medical AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 19.07M$ 13.09M$ 2.56M$ 232.31K$ 75.67K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 27.05M$ 3.29M$ 2.86M$ 75.67K$ 85.99K
EBITDA
$ -46.56M$ -27.77M$ -21.02M$ -14.29M$ -12.84M
Operating Income
$ -73.72M$ -31.05M$ -23.92M$ -14.38M$ -12.96M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -73.69M$ -31.09M$ -24.51M$ -14.94M$ -12.97M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

PEPTONIC medical AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis